Discover the detailed record of transactions filed by Fredrik Alpsten, Président du Conseil. Director active across 8 companies, notably Prolight Diagnostics. Cumulatively, 4 filings have been recorded. The latest transaction was disclosed on 18 December 2025 — Purchase. Regulator: FIN-FSA. The full history is openly available.
4 of 4 declarations
Fredrik Alpsten is the Chairman of Prolight Diagnostics. He plays a key role in overseeing the activities of the board of directors and in the strategic direction of the company. Alpsten brings valuable expertise in the field of medical diagnostics, contributing to the innovation and growth of Prolight Diagnostics. His commitment to corporate governance is essential for the success of the organization.